European Industry Associations, CGP Coalition & LC Policy Network
References: 1. Guardant360® CDx Technical Information. February 2023. Guardant Health, Inc. Redwood City, CA.
2. FDA News Release. FDA approves first liquid biopsy next-generation sequencing companion diagnostic test. August 7, 2020. Accessed
May 20, 2024.
https://www.fda.gov/news-events/press-announcements/fda-approves-first-liquid-biopsy-next-generation-sequencing-companion-diagnostic-test
A suite of revolutionary blood-based residual disease and CGP tests to inform treatment decisions1,2
Public-Private-Partnerships